https://www.marketscreener.com/quote/stock/TELO-GENOMICS-CORP-56976453/news/Telo-Genomics-Corp-Launches-A-Minimal-Residual-Disease-Clinical-Trial-in-Multiple-Myeloma-42283691/?utm_source=telegram&utm_medium=social&utm_campaign=share